Skip to content
Sign up to receive our free weekday morning edition, and you'll never miss a scoop.

Government shutdown (still) likely, K Street leaders say

Most K Street leaders (82%) say there will likely be a government shutdown between now and January 2024, according to our recent survey, The Canvass.

As a reminder, Rep. Kevin McCarthy (R-Calif.) was ousted from his role as speaker over his decision in September to negotiate a continuing resolution with Democrats to keep the federal government open. That CR expires in just 18 days — on Nov. 17.

Newly elected Speaker Mike Johnson has already said he wants a stopgap funding bill until January or April of next year. Many House conservatives seem to be willing to give him time to settle in, and so are open to a CR for now. But there’s already been some pushback in the Senate, where appropriators don’t want to go into next year still operating under a short-term continuing resolution.

Breaking down this month’s survey by party affiliation, there isn’t much daylight between Democratic or GOP lobbyists — 85% of Democrats and 79% of Republicans say a shutdown in 2023 is likely. The survey was conducted Oct. 2 to Oct. 20 in partnership with LSG.

This survey was fielded shortly after Congress narrowly avoided a government shutdown at the end of September and continued for much of the duration of the chaotic speaker race.

Senior staffers on Capitol Hill were generally aligned with K Street on the likelihood of a shutdown when we asked them the same question in September — 92% predicted there would be one this year.

Interested in being a part of our survey? The Canvass provides anonymous insights each month from top Capitol Hill staffers and K Street leaders on key issues facing Washington. Sign up here if you work on K Street. And click here to sign up if you’re a senior congressional staffer.

Presented by AstraZeneca

The 340B program was created to help patients. Instead, it’s helping hospitals earn massive profits. The 340B Rebate Model Pilot uses rapid verification of existing data to prevent duplicate discounts, strengthening program transparency and efficiency. Urge HHS to implement the Rebate Model Pilot and ensure 340B functions as intended. Get the facts.

Editorial photos provided by Getty Images. Political ads courtesy of AdImpact.

Presented by AstraZeneca

The 340B program is supposed to help vulnerable patients—but without strong safeguards, it’s siphoning away funds that could be used for free and charitable medicine. The 340B Rebate Model Pilot improves program integrity, preventing duplicate discounts and strengthening accountability. Urge HHS to implement the pilot today. Learn why it matters.

Welcome to Punchbowl News AM! We're glad to have you here.

Want to get more of what you need? Share a bit more about yourself to help us tailor your reader experience.

Thank you for signing up!

Thank you for signing up!

 

We have sent you a confirmation email. Please follow the provided instructions to complete your sign-up.

Thank you for confirming! You are now subscribed to the Punchbowl News AM list.

You're subscribed! Welcome to the community.